SirnaMed Therapeutics Inc.

SEWICKLEY, PA · Founded 2023 · CIK 0002031257 · Biotech · Private

RNA interference (RNAi) therapeutics targeting cancer-causing genes

sirnamed.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$1.3M
1 Form D · Jul 2024
27 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$1,250,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1473RESBIOTIC, INC.—$1.6M
1474UBIVAC, INC.—$1.5M
1475EXSCIEN CORPORATION——
1476SirnaMed Therapeutics Inc.—$1.3M
1477AstralBio, Inc.—$957K
1478ACHERX LLC——
1479General LED, Inc.—$941K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 4 related persons
  • Jing-Zhou HouDirector · Executive Officer · Promoter
  • Song LiDirector · Executive Officer · Promoter
  • Stanley MarksDirector
  • Phong TranExecutive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.